Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 252 UK diagnostics and biomarkers companies below.
Non-invasive vaginal sampling for gynaecological disease
Ellele Health is a medical research company developing a minimally invasive vaginal sampling device and associated downstream assays for the detection and management of gynaecological conditions. Using a proprietary biospecimen collected from the vaginal wall, the company applies genetic, epigenomic, and microbial…
Gut microbiome tests predicting biologic drug response in IBD
AlphaBiomics is a precision medicine company developing diagnostics that analyse the gut microbiome to guide treatment decisions. Its lead test uses a stool sample collected at home and machine learning analysis of microbial sequencing data to predict which patients with inflammatory bowel disease are likely to…
DNA, drug, and alcohol testing laboratory for legal and workplace clients
AlphaBiolabs is a UKAS-accredited laboratory providing DNA relationship and paternity testing, drug and alcohol testing, and health screening services. The company serves the legal profession, businesses, social services, and the general public, with results accepted by the Ministry of Justice, Home Office, and UK…
Sperm DNA fragmentation diagnostics for male fertility assessment
Examen is a Belfast-based diagnostics company specialising in male reproductive health. Its proprietary assay-based technology measures single-strand and double-strand sperm DNA breaks to provide a clinically actionable assessment of male fertility beyond conventional semen analysis parameters. Tests are…
Single-cell somatic mutation analysis for measuring biological ageing
AgeCurve is a geroscience company developing diagnostics that measure biological ageing at the level of individual cells. Its approach analyses the burden and lineage structure of somatic mutations in single cells, combining genotype with cellular phenotype data through machine learning to estimate how far ageing has…
Solvent-free gold nanoparticles for lateral flow and IVD diagnostics
Grove Nanomaterials is a Welsh nanotechnology company developing a sustainable, solvent-free manufacturing process for gold nanoparticles used in lateral flow assays and in-vitro diagnostics. Based on patented nanoparticle beam deposition technology developed at Swansea University, the process eliminates the chemical…
Lab-on-PCB biosensors for non-invasive point-of-care diagnostics
TeslaDiagnostiX develops miniaturised electrochemical diagnostic systems using lab-on-printed-circuit-board technology for biological sample testing. Its lead programme is a quantitative saliva glucose assay intended to provide a non-invasive alternative to blood-based measurement. The device combines disposable PCB…
Rapid molecular tests for industrial and bioprocess contamination
Fuse Diagnostics develops rapid, low-cost molecular tests for use at the point of need. Its disposable tests use proprietary amplification chemistry to detect pathogens and contaminants in under ten minutes, without requiring specialist laboratory infrastructure. The company targets applications in bioprocessing, cell…
Immunoaffinity test kits for food, feed, and clinical diagnostics
R-Biopharm Rhône is a Glasgow-based manufacturer and distributor of immunoaffinity columns and analytical test kits for food safety, feed analysis, and clinical diagnostics. The company manufactures immunoaffinity products for mycotoxin, vitamin, and antibiotic analysis under several brands, and distributes R-Biopharm…
Molecular controls manufacturer for infectious disease diagnostics
Qnostics is a manufacturer of molecular controls for use in molecular diagnostic laboratories and IVD product development. The company develops, manufactures and distributes a portfolio of characterised viral, bacterial and fungal reference materials for infectious disease targets, supporting assay performance…
Laboratory information systems and digital pathology software
Cirdan is a medical software company developing laboratory information systems and digital pathology solutions for clinical laboratories and pathology departments. Its integrated platform streamlines laboratory workflows, supports multi-site operations, and applies AI and data analytics to accelerate patient…
FDA-approved AI blood test for diabetic kidney disease risk
Renalytix is an artificial intelligence-enabled in vitro diagnostics company focused on the clinical management of chronic kidney disease. Its blood-based test combines biomarker analysis with machine learning to generate a five-year kidney function decline risk score in adults with type 2 diabetes and CKD stages 1 to…
AI-driven liquid biopsy platform for early cancer biomarker discovery
BioMavericks is an early-stage biotechnology company developing an AI-driven liquid biopsy platform for the early detection of cancer. Its lead product targets the discovery and validation of blood-based biomarkers for early-stage pancreatic cancer diagnostics, integrating molecular cell biology, multi-omics data…
Isothermal molecular diagnostics and assay development services
Simplex Molecular is a biotechnology company developing instrument-free nucleic acid testing technology alongside molecular biology research services. Its proprietary isothermal amplification chemistry operates at room temperature and is being developed into a portable, multiplexed diagnostic platform with…
Canine gut microbiome testing and personalised supplement service
BIOME9 is a canine health company providing at-home gut microbiome testing and personalised supplement plans for dogs. Using stool sample analysis and AI-assisted interpretation, the company generates detailed gut health reports identifying microbial imbalances and tailored dietary recommendations. Operating as the…
Non-invasive mitochondrial DNA damage testing for skin health research
Skin Life Analytics is a biotechnology company providing PCR-based testing services that quantify mitochondrial DNA damage in skin using non-invasive swab sampling. The technology detects molecular markers of skin ageing, UV damage, and environmental stress before visible signs appear. Services include direct testing…
DNA methylation blood tests for ovarian and pancreatic cancers
GenoME Diagnostics is a biotechnology company developing molecular blood tests for cancer detection and monitoring. Its liquid biopsy platform identifies DNA methylation and fragmentomic biomarkers, combining them into multiplexed droplet digital PCR assays. Its lead test targets ovarian cancer recurrence and…
Blood glycomic biomarkers for chronic inflammatory disease detection and monitoring
Avenna is a biotechnology company developing blood-based glycomic biomarkers for chronic inflammatory diseases. Its tests analyse the sugar structures attached to blood proteins to measure chronic inflammation separately from short-term acute inflammation, supporting early detection, disease monitoring and…
Custom modified oligonucleotides for research and therapeutics
ATDBio is a University of Southampton spin-out specialising in custom DNA and RNA oligonucleotide synthesis for research, diagnostics and therapeutic development. Its Southampton-based operations supply standard and chemically modified oligos, including antisense sequences, siRNA, aptamers and labelled probes, using…
Blood-based CIZ1B biomarker test for early-stage lung cancer detection
Cizzle Biotechnology is a UK-based diagnostics company developing a non-invasive blood test for the early detection of lung cancer. The company's CIZ1B biomarker test identifies a stable plasma biomarker highly correlated with early-stage disease, offering an alternative to imaging or biopsy procedures. Cizzle's test…